Chase Investment Counsel Has Lowered Ss&C Technologis Hldgs (SSNC) Holding By $3.39 Million; Invivo Therapeutics Holdings (NVIV) Shorts Down By 11.19%

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Logo

Chase Investment Counsel Corp decreased SsC Technologis Hldgs Inc (SSNC) stake by 79.6% reported in 2018Q4 SEC filing. Chase Investment Counsel Corp sold 75,225 shares as SsC Technologis Hldgs Inc (SSNC)’s stock rose 28.20%. The Chase Investment Counsel Corp holds 19,274 shares with $869,000 value, down from 94,499 last quarter. SsC Technologis Hldgs Inc now has $16.50 billion valuation. The stock decreased 0.58% or $0.38 during the last trading session, reaching $65.29. About 1.00M shares traded. SSC Technologies Holdings, Inc. (NASDAQ:SSNC) has risen 25.58% since April 14, 2018 and is uptrending. It has outperformed by 21.21% the SP500. Some Historical SSNC News: 06/04/2018 – Fidessa Remains in Talks With ION, SSC About Possible Alternative Offers; 06/03/2018 Esposito Securities Switches to SSC’s MarketTrader; 06/04/2018 – SSC Technologies: Any Offer Likely to

... read more at: